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Abstract
Background: Tolerance and resistance provide animals with two distinct strategies to fight infectious pathogens
and may exhibit different evolutionary dynamics. However, few studies have investigated these mechanisms in the
case of animal diseases under commercial constraints.
Methods: The paper proposes a method to simultaneously describe (1) the dynamics of transmission of a
contagious pathogen between animals, (2) the growth and death of the pathogen within infected hosts and (3)
the effects on their performances. The effectiveness of increasing individual levels of tolerance and resistance is
evaluated by the number of infected animals and the performance at the population level.
Results: The model is applied to a particular set of parameters and different combinations of values. Given these
imputed values, it is shown that higher levels of individual tolerance should be more effective than increased levels
of resistance in commercial populations. As a practical example, a method is proposed to measure levels of animal
tolerance to bovine mastitis.
Conclusions: The model provides a general framework and some tools to maximize health and performances of a
population under infection. Limits and assumptions of the model are clearly identified so it can be improved for
different epidemiological settings.
Background
The breeding objective in most livestock species is to
increase profit by improving performance efficiency.
One way to reach this objective is to improve the ani-
mals’ health, for example, through the implementation
of appropriate management methods (e.g. chemother-
apy, vaccination, and control of disease vectors). A more
sustainable method consists in taking advantage, by
selective breeding, of the within-breed variation that
exists in the mechanisms of defenses against infectious
pathogens [1]. Indeed, hosts have evolved resistance and
tolerance defenses [2], thus breeders may choose, as
progenitors, animals with the highest levels of resistance,
tolerance, or both. One the one hand, resistance is the
ability of the host to reduce the success of infection or
to increase the rate of clearance of the pathogens. On
the other hand, tolerance is the ability to reduce the
detrimental effects of the pathogens on the perfor-
mances of the hosts, either directly or by limiting
immunopathological mechanisms [3]. The rate of trans-
mission diminishes naturally among resistant hosts but
not necessarily among tolerant ones, as these harbor the
pathogen with no or moderate loss in performance [4].
Resistance and tolerance are associated with fitness
costs, which arise from the diversion of limiting
resources away from biological processes related to per-
formance [5]. If these costs are too high, they may out-
weigh the effectiveness of the chosen strategy. Direct
evidence of such costs can be found in experiments in
insects [6], rainbow trout [7], crustaceans [8], wild birds
[9] and mice [10].
To decide whether improving resistance, tolerance,
neither, or both is the most effective strategy, it is pro-
posed to (1) characterize the dynamics of the pathogens
within and between hosts in the population under study,
(2) evaluate the impact of the infection on the perfor-
mances of the population, and (3) choose the most
effective strategy. The goal of this study is to illustrate
the methodology with a non-lethal micro-parasitic dis-
ease in a population where hosts have different levels of
resistance to multiplication of the pathogen and
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by the pathogens.
Methods
Pathogen dynamics
The model chosen here to depict the dynamics of
transmission of the infection in a herd is a stochastic
version of the SIS (S for susceptible, I for infected)
model for the spread of a disease in a closed popula-
tion of N individuals [11]. This model is appropriate
for infections with no permanent immunity after
recovery, i.e. individuals are susceptible to the infec-
tion, potentially get infected, may recover and become
susceptible again. The time-scale of the disease process
is assumed to be short compared to the life length of
the host and no demographic turnover (natural birth
or death) is considered. The area occupied by parasites
and hosts is constant, so that numbers and densities
coincide. There is only a single non-evolving pathogen
species within infected hosts. Once infected, hosts are
immediately able to infect other individuals (no latent
period). Within the host, the number of pathogens
increases following a sigmoidal growth curve and is
directly related to the number of immune constituents
of the host response to the pathogen, with no distinc-
tion between innate and specific immunity. Recovered
hosts are as susceptible to infection as naïve hosts and
re-exposure does not accelerate development of the
disease.
In mathematical terms, the process is described by a
continuous time Markov chain, {C
i
t;t=0t oT ,i=1t o
N}, where C
i
t denotes the number of pathogens in the
i
th host at time t. Units of time are chosen arbitrarily.
The chain has three transition probabilities (over a
small time interval Δt) reflecting the three events, i.e.
invasion of a new host by the pathogen, its multiplica-
tion and its killing by the immune response of the host.
The first transition probability is the probability the i
th
susceptible host is infected by Cmin pathogens:
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where o(Δt) tends to 0 when Δti ss m a l l ,C min is the
minimum number of pathogens necessary to have infec-
tion, b is the per-capita rate of successful transmission
of Cmin pathogens from an infectious host to a suscepti-
ble host upon contact with an infectious individual and
during Δt, and It is the number of infectious hosts with
which the i
th susceptible has contact.
The second transition probability is the probability
that a pathogen in an infected host gives birth to Cmin
new offspring, such that this host becomes infectious:
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where g is the pathogen growth rate. Right after
becoming infected, pathogen growth in a host is
approximately exponential but it slows down as it
reaches a maximum (C
Max), at which it stops.
The last transition probability is the probability that
Cmin pathogens are killed within the host:
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This equation follows from the dynamics between
pathogens and immune factors, as observed in experi-
mental studies [12,13]. Parameter μ represents the maxi-
mum number of pathogens killed for each unit of R
i
t,
with R
i
t being a generic index related to the number, at
time t, of the different types of immune factors specific
for that pathogen. Because the main interest is on the
number of pathogens, the complexity of the immune
response is greatly simplified when R
i
t increases at a
rate (h
i) that is constant across time. The scaling para-
meter r
i varies from 0 to 1 and represents the extra
investment in resistance of the i
th host with respect to
μ.W h e nC
i
t drops below Cmin, the infection is assumed
to be cleared.
The Markov chain was simulated using the Gillespie
algorithm [14], which essentially uses exponential wait-
ing times between events. For all simulations, it was
assumed that two individuals in the population were
initially infected. Simulation steps were executed until t
reaches T units of time (= one replicate) and repeated
over 50 replicates. Each cycle took around 4 hours to
complete, so the population size was limited at 30 indi-
viduals, which is the average size of most dairy herds in
the Walloon region of Belgium.
Individual performance
The performance of an infected host decreases propor-
tionally to the number of pathogens (C
i
t)a n dt oi n v e s t -
ments of the host in tolerance [15]:
PP C 1 t
i
t=0
i
t
ii =− ω − () ,  (4)
where P
i
t is the performance of the i
th host at time t,
when it is infected with C
i
t pathogens, ω is the maxi-
mum amount of performance lost per pathogen (viru-
lence). The parameter l
i is a scaling parameter
representing the extra investment in tolerance. If l
i =1 ,
the host is completely tolerant and produces at a level
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i = 0, the host
is not tolerant to the deleterious effects of the pathogen.
Hosts invest part of their constitutive resources to
resist or tolerate the pathogens and costs are assumed
proportional to the investments in both types of defense.
They are combined in an additive way:
PP c c t=0
i M a x ii ii (- - ) , = 1 ρλ ρλ (5)
where P
Max is the totality of the resources available to
the host to insure performance (e.g., production, repro-
duction, work) and to cope with an infection (resistance
and tolerance). If no extra-investments are put in resis-
tance and tolerance, all resources are allocated to insure
the highest achievable level of performance in the
absence of infection. Parameter c
i
r is the marginal cost
of resistance and c
i
l is the marginal cost of tolerance (in
units of performance). Values for both costs are con-
strained such that the factor within brackets remains
positive (r
i c
i
r + l
i c
i
l ≤ 1). A constraint was also set to
insure P
i
t (equation 4) remains positive or null in totally
non-tolerant individuals infected with K pathogens: ω ≤
P
Max(1 - r
i c
i
r)/K.
Typical patterns in performance as a function of num-
ber of pathogens are shown schematically in Figure 1 to
illustrate the different ways resources can be allocated
between resistance, tolerance and performance (costs
are assumed equal for resistance and tolerance). Perfor-
mances of hosts allocating none of the available
resources to resistance and tolerance are the highest at
the start of infection (Pt=0=P
Max) and decrease as Ct
increases. Numbers of pathogens remain below 20
among resistant hosts, and performances of tolerant
hosts do not decline with increasing parasite burden.
Effectiveness analysis
The most profitable strategy, i.e. the one that will insure
the lowest number of infected animals or the highest
performance of the population, or both, was identified
by weighing the allowed extra investments in resistance,
tolerance, or both, against the effectiveness of each of
these alternatives.
Effectiveness was computed by comparing populations
under the same infection process but in which animals
invest (’yes’ population) or not (’no’ populations) in
r e s i s t a n c e ,t o l e r a n c e ,o rb o t h .T od os o ,t h en u m b e r
of infected hosts (It) and the overall performance (Pt =
Σi=1 , NP
i
t) were followed across time, and the area
under the curves of Pt (AUCP)a n dI t (AUCI)w e r e
obtained for t = 0 to T with the spline method of the
procedure Expand of SAS
® [16]. Subsequently, the
incremental effects (ΔEI and ΔEP) were computed as the
difference between corresponding ‘yes’ and ‘no’ popula-
tions: ΔEI =A U C I
no -A U C I
yes,a n dΔEP =A U C P
yes -
AUCP
no. Then, the most effective alternative was identi-
fied as the one with the highest values for ΔEI and ΔEP.
Incremental effects were calculated for different sets of
parameters (Table 1). Two transmission rates were con-
sidered, with b =0 . 1a n db = 0.5, which correspond to a
new infection per 10 and 2 effective contacts, respec-
tively. The minimum number of pathogens was set to
Cmin = 10 and the maximum to C
Max =5 0 0 .T h eg r o w t h
rate (g)w a ss e ta t0 . 5n e wp a t h o g e n sf o re a c he x i s t i n g
o n ea n dt h ev a l u ef o rμ was set to 0.25 or 1.0 to obtain
killing rates equal to half or twice the pathogen growth
rate. A convenient value of 100 was given to P
Max, while
virulence (ω) was set at 0.1 or 0.2 units of performance
lost per pathogen present. Individual extra investments
in resistance and tolerance were drawn from uniform dis-
tributions with different extreme values to have low (U[0,
0.5]), average (U[0, 1]), or high (U[0.9, 1]) levels of invest-
ments. Associated costs were drawn from uniform distri-
butions within the allowable limits imposed by equations
(4) and (5): U [0, 0.1], U [0.1, 0.2], and U [0.2, 0.5].
Finally, effects of low, average and high levels of extra-
investments in resistance and tolerance on ΔEI and ΔEP
were quantified using fixed linear models (proc GLM on
SAS
® [16]) that also contained the effects of b, μ, and ω
for the characteristics of the pathogen, the averages at
the population level of h
i,c
i
r and c
i
l for the characteris-
tics of the hosts, and all first-order interactions. The
resulting least-squares estimates were used to identify
epidemiological situations for which investments in tol-
erance, resistance or both were effective.
Results
Within-host pathogen dynamics
The number of pathogens within a host is shown in
Figure 2 for 10 animals in a ‘no’ population with the
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Figure 1 Schematic representation of the impact of resource
allocation on performance (P) and number of pathogens (C).
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Page 3 of 10following characteristics: b =0 . 5 ;μ =0 . 1 ;ω =0 . 1 ;h
i ~
U [0, 0.001], and r
i = l
i = 0 for i = 1 to N. The duration
and the number of pathogens generated were approxi-
mately the same for all animals because they depended
on g = 0.5 (equation 2). However, the stochastic nature
of the simulation resulted in a cloud of points for each
C
i
t.O na v e r a g e ,C
Max was reached after 300 time units,
so it was used as the upper limit for T because the Gil-
lespie algorithm was slow to converge and because T =
300 insured the steady value C
Max was reached among
completely non-resistant hosts.
In Figure 3, the dynamics in C
i
t and P
i
t are shown for
four individuals with different investments and costs of
resistance and tolerance, and for an infection with b =
0.5, g = 0.5, ω = 0.2, h
i ~ U [0, 0.1], and μ = 0.25. When
both r
i and l
i were high, C
i
t remained low and P
i
t did
not change much across time (individuals □ or +).
Conversely, when r
i was low, C
i
t increased up to its
maximum and the associated individual performance
decreased (individual ○ in Figure 3). Between these
extremes, a wide range of different situations occurred.
Initial performance (P0)v a r i e da c c o r d i n gt ot h e
costs and extra investments in tolerance and resistance
(equation 3).
Between-host pathogen dynamics
The number of infected hosts (It) and the overall perfor-
mance (Pt) are given in Figure 4 as percentages of their
maximum values (N and P
Max, respectively) and for an
infection with b =0 . 5 ,g =0 . 5 ,ω =0 . 1 ,a n dμ = 0.25.
At T = 300, all individuals in the ‘no’ population
(Figure 4a) were infected (with the exception of one)
and the overall performance was close to 50%, which is
the minimum expected from equation 5 when all
Table 1 Model parameters and their values
Symbol Description Values
Pt
i Performance for animal i at time t
Ct
i Pathogen number in animal i at time t
Rt
i Immune response in animal i at time t
It Number of infected animals in the population at time t
Pt Population performance at time t
ΔEP Incremental effectiveness for Pt over the T period
ΔEI Incremental effectiveness for It over the T period
N Population size 30
T Time duration 300
Cmin Pathogen number necessary for infection 10
C
Max Maximum number of pathogens 500
P
Max Maximum performance 100
g Per-capita pathogen growth rate 0.5
b Transmission rate 0.1; 0.5
μ Maximum per-capita pathogen killing rate 0.25; 1.0
ω Maximum performance loss per pathogen 0.1; 0.2
c
i
r Marginal costs of resistance U [0, 0.1]; U [0.1, 0.2]; U [0.2, 0.5]
c
i
l Marginal costs of tolerance U [0, 0.1]; U [0.1, 0.2]; U [0.2, 0.5]
r
i Extra investment in resistance U [0, 1]; U [0,0.5]; U [0.9, 1]
l
i Extra investment in tolerance U [0, 1]; U [0, 0.5]; U [0.9, 1]
h
i Rate of increase for the immune index U [0, 0.001]; U [0, 0.01]; U [0, 0.1]
Figure 2 Number of pathogens across time for 10 completely
susceptible hosts.
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Max
pathogens.
When individuals invested more in resistance, only a
fraction of the population got infected and AUCI was low.
For example, AUCI decreased from 22,720 to 19,379 and
13,851 infected hosts in Figures 4b (r =0 . 2 2 ) ,4 e( r =
0.46), and 4h (r = 0.94), respectively. When the average
level of extra investments in tolerance was high (around
0.95), the impact of It on Pt was almost zero (Figures 4d,g
and 4j). Otherwise, Pt decreased as It increased, especially
for low levels of tolerance (Figures 4b,e and 4h). This
should have translated in an increase in AUCP but, in this
particular population, costs associated with tolerance were
high (around 0.15) and initial performance was low. For
example, P0 averaged 79.8 in Figure 4g (l = 0.95; AUCP =
23,509) and 90.4 in Figure 4e (l = 0.25; AUCP = 24,779).
Effectiveness analyses
Values of ΔEP and ΔEI obtained for each combination of
the parameters of Table 1 are shown in relation to r
and l in Figure 5. Each dot corresponds to one specific
combination of the parameter values. Effective combina-
tions, those associated with both ΔEP>0 and ΔEI>0,
represented 75.7% of all combinations. There was a
tendency for ΔEI and ΔEP to increase with increasing
values for r and l, respectively. However, there were
also combinations of parameters for which high values
for r or l were not effective, as revealed by the analysis
of variance.
Results from the analysis of variance identified signifi-
cant (p < 0.01) effects of r
i,c r,h
i,a n dμ on ΔEI,a n do f
l,c l, b,a n dω on ΔEP. All first-order interactions were
non-significant (p > 0.10). Incremental effects are given
in Tables 2 and 3 for selected combinations. Overall,
ΔEP was greater for higher values of l but, for moder-
ately virulent (ω = 0.1) and slow spreading (b = 0.1) dis-
eases, investments in tolerance were low or ineffective
unless they incurred at low costs (Table 2). Investing in
resistance (Table 3) was effective for infections that eli-
cited moderate to high but not low (h
i ~ U[0, 0.001])
immune responses in the hosts (unless levels of resis-
tance were high).
Discussion
A general framework is proposed to provide insights
into the effects of improved resistance and tolerance on
the performance and size of an infected population.
A clear distinction is made between effects of resistance
on multiplication of the pathogen and effects of toler-
ance on damages induced by the pathogens. Hosts differ
in the costs they incur to insure their particular levels of
resistance and tolerance, and in the intensity of the
response they mount against pathogens. Pathogens differ
in their speed of spread between hosts, in virulence, and
in the intensity of the response they elicit in the hosts.
However, to be useful, the model must be validated and
its limits and assumptions must be clarified, as will be
discussed in the following, with examples mostly related
to bovine mastitis.
Validation of the model
Model validation usually takes the form of a compari-
son between model outputs and real data but this was
not possible here because reliable field data are scarce,
difficult to measure or imprecisely defined [17,18]. For
example, estimates of costs associated with resistance
and tolerance are limited in animals, in contrast to
plants (see review by [19]). Tolerance has often been
measured imprecisely as the overall ability to maintain
fitness in the face of infection, irrespective of parasite
burden. For example, cows infected with E. coli have
been classified as moderate and severe responders
according to milk production loss in the non-
challenged quarters [20]. In this case, it is in reality a
measure of the combined effects of resistance and tol-
erance [4]. It was also a deliberate choice to present a
generic model because parameters values are different
among disease and host populations, so model outputs
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Figure 3 Within-host dynamics for the number of pathogens
and performances of four individuals with different levels of
resistance (r) and tolerance (l). Associated costs are in
parentheses.
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ease. For example, transmission rates have been esti-
mated at 0.20 to 1.50 per 1000 quarter-days at risk for
S. uberis mastitis [21] but at 7 to 50 for S. aureus mas-
titis [22]. Similarly, killing rates have been estimated at
0.67 to 1.33 × 10
-8 mL/cell per min in milk of cows
[23,24] and at 1.64 to 1.76 × 10
-8 mL/neutrophil per
min in dermis of rats inoculated with E. coli [13].
Model outputs will also depend on the virulence of the
invading pathogens (ω), as exemplified by the different
amount of milk loss at the first occurrence of clinical
mastitis depending on bacteria species [25], and on the
type of performance (e.g., yield, quality of products, or
capacity for work) considered.
As an alternative form of validation, the dynamics of
C
i
t and P
i
t at the individual, and of It and Pt at the herd
levels were evaluated. For instance, as expected, C
i
t was
lowest in resistant and P
i
t was highest in tolerant hosts
(Figure 3), Pt remained stable across time when toler-
ance of the hosts was at its highest level, and It
decreased faster when resistance of hosts was at its
highest level (Figure 4). Results from the analysis of var-
iance also validated the model. The null value of ΔEI for
h
i~U [0, 0.001] was sensible because, at this low rate,
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Figure 4 Number of infected individuals (solid line) and overall performance (broken line) in populations with different average
values for levels of resistance (r) and tolerance (l), and for their associated costs (cr and cl in parentheses). The values are expressed
as percentages of their maxima.
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invested in resistance. The fact that b did not affect ΔEI
m a ya l s ob ee x p l a i n e db yt h es a m et r a n s m i s s i o ni n‘yes’
and ‘no’ populations, so AUCI
yes was close to AUCI
no
for any value of b. As a final example, ΔEP was higher
for b =0 . 5t h a nf o rb =0 . 1b e c a u s eo n l yf e wa n i m a l s
got infected with b =0 . 1 ,s oi m p r o v i n gt o l e r a n c eo f
these few hosts was not beneficial at the population
level.
Limits and assumptions of the model
The strategy to build this model followed the current
trend in epidemiology to begin with simple models and
to add complexity only if the model fails to reproduce
plausible epidemiological behaviors [26]. Several
assumptions were made, some of which have been con-
firmed previously. One assumption was that available
resources are partitioned between performance, resis-
tance and tolerance. Indeed, experiences in poultry [27]
and other species [28] have shown that individuals differ
in their ability to allocate resources to their needs. This
is also one of the factors evoked to explain the increased
susceptibility of high yielding dairy cows to mastitis [29].
Lack of resources may lead to vicious cycles because
hosts in poor condition are more susceptible to higher
pathogen occurrence and infection intensity, which
further weaken the condition of the host [30]. Another
assumption is that investments in resistance and toler-
ance are linked through the constraint in equation 4
and this has been confirmed by [2], where a negative
relationship was found between resistance and tolerance
in rodent malaria.
Some assumptions of the model could also be relaxed
with more complex equations that have been used in
models examining the effects of mixed infection [21],
infectious dose [31] and vaccination/treatment [32] on
transmission dynamics. Resistance could vary as a func-
tion of exposure to disease [33]. Availability of external
resource can vary across time, as in Doesch-Wilson et
al. [34]. In the model used here, individual infectious
contacts were assumed independent and at random but
models with heterogeneous mixing [35] and that
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Figure 5 Incremental effectiveness for performance (ΔEP) and number of infected individuals (ΔEI) for different investments in
resistance (r) and tolerance (l) and for various characteristics of the infection (Table 1).
Table 2 Incremental effectiveness of the performance of
the population (ΔEP) associated to different investments
in individual tolerance (l
i) and for selected values of c
i
l,
b and ω, as defined in Table 1
l
i ~ U[0,0.5] l
i ~ U[0.9,1]
c
i
l b ω ΔEP c
i
l b ω ΔEP
0 0.1 0.1 1623 0 0.1 0.1 2974
U[0.2,0.5] 0.1 0.1 -628 U[0.2,0.5] 0.1 0.1 722
0 0.1 0.2 5635 0 0.1 0.2 6986
U[0.2,0.5] 0.1 0.2 3383 U[0.2,0.5] 0.1 0.2 4734
0 0.5 0.1 4198 0 0.5 0.1 5549
U[0.2,0.5] 0.5 0.1 1946 U[0.2,0.5] 0.5 0.1 3297
0 0.5 0.2 8210 0 0.5 0.2 9561
U[0.2,0.5] 0.5 0.2 5958 U[0.2,0.5] 0.5 0.2 7309
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may be more appropriate. The course of infection within
hosts can also be modelled more accurately, in line with
the characteristics of the disease under study. For exam-
ple, models with increasing complexity have been pro-
posed to describe the fate of mastitis-causing E. coli in
infected cows [23,24]. Models for co-evolutionary
mechanisms between host and pathogens should be
considered [38] if the time scale is longer than the one
used in this study.
Other assumptions may be difficult to verify. For such
assumptions, a set of arbitrary standard values for the
parameters and different forms for equations should be
tested in so-called sensitivity analyses. For example, the
amount of loss in performance was assumed directly
associated with pathogen load, although the most dra-
matic changes may occur at low or subclinical levels of
disease, with diminishing effects of each additional para-
site [39].
Effectiveness analyses
Two results from the effectiveness analyses are note-
worthy, although they must be further evaluated in
empirical studies. One is that the range of possible
values of ΔEP and ΔEI for the different input parameters
(Figure 5) is wide. This emphasizes the need to accu-
rately model the infection process and its impact on the
population before deciding on the most effective strat-
egy. For example, increasing host tolerance is theoreti-
cally less effective for improving performance of
populations infected with pathogens that cause minor
rather than major mastitis. Indeed, pathogens causing
minor mastitis are less virulent (ω) and less transmissi-
ble (b) than those causing major mastitis [40], so mod-
est advantages of high tolerance would be offset by the
associated costs. Likewise, selecting for better resistance
to mastitis would be effective to restrict the size of a
population epidemic if animals are infected with bacter-
ial strains that are likely to be killed by neutrophils [41],
i.e. μ>0 in equation 3.
Another noteworthy observation is that least-squares
means for ΔEP were highest in highly tolerant popula-
tions, while ΔEI did not change between different tol-
erance levels. This suggests that selection for increased
tolerance would be effective under commercial con-
straints. This is different from models applied to nat-
ural populations that predict an increase in the overall
incidence of infection as the frequency of tolerant
hosts increases [38]. In natural populations, tolerant
hosts survive longer than non-tolerant ones, thus keep-
ing the disease longer in the population and increasing
the risk of exposure to disease. Here, the model is for
an endemic disease in a population under commercial
contraints, in which non-tolerant animals are kept
even if they are sick (no natural death, no culling).
Consequently, the risk of exposure to disease does not
change, even if the pathogen population size (C)
increases.
In general, little is known about tolerance mechanisms
in animals but their study should provide a good founda-
tion for insuring health over the long term. Indeed, in the
long term, advantages of being tolerant should be greater
than those associated with resistance. For example, in
non-evolving pathogen populations, advantages of being
resistant decrease in parallel with the decline in disease
frequency, while the advantages of being tolerant are
maintained, or even increase if disease frequency rises
[42]. In evolving pathogen populations, improved host
resistance will pressure pathogens to evolve better
mechanisms to evade host defense processes, potentially
resulting in cyclical co-evolutionary dynamics. In contrast,
tolerance does not interact directly with the pathogen and
should not induce selection for counter-adaptations,
although elevated levels of tolerance may allow pathogens
to be more virulent [43].
Practically, in bovine mastitis, it the degree of toler-
ance of an animal can be estimated by the amount of
milk loss per bacteria present in the quarter (CFU)
using a model adapted from that proposed by [2] for
inbred strains of laboratory mice:
Table 3 Incremental effectiveness of the number of infected (ΔEI) associated to different investments in individual
resistance (r
i) and for selected values of c
i
r, μ and h
i, as defined in Table 1
r
i ~ U[0,0.5] r
i ~ U[0.9,1]
c
i
r h
i μ ΔEI c
i
r h
i μ ΔEI
U[0.2, 0.5] U [0, 0.001] 0.25 -808 U[0.2, 0.5] U [0, 0.001] 0.25 1509
0 U [0, 0.001] 0.25 -1215 0 U [0, 0.001] 0.25 1103
U[0.2, 0.5] U [0, 0.001] 1 -127 U[0.2, 0.5] U [0, 0.001] 1 2191
0 U [0, 0.001] 1 -533 0 U [0, 0.001] 1 1784
U[0.2, 0.5] U [0, 0.1] 0.25 5607 U[0.2, 0.5] U [0, 0.1] 0.25 7925
0 U [0, 0.1] 0.25 5201 0 U [0, 0.1] 0.25 7518
U[0.2, 0.5] U [0, 0.1] 1 6289 U[0.2, 0.5] U [0, 0.1] 1 8607
0 U [0, 0.1] 1 5882 0 U [0, 0.1] 1 8200
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t
ij i j
t
ij ij
t
ij
t =+ + + μ ,
where yij
t i st h em i l ky i e l da tt i m eto ft h ei
th cow
(yield corrected for fixed and non-genetic random
effects estimated from the genetic evaluation model)
infected with Iij
t, i.e. the bacterial load for bacterial spe-
cies j; bj is the average tolerance against bacteria of
strain j; Bij describes individual random deviations from
the average tolerance with Bij ~ IID N(0, s²b); and eij
t
are residuals with eij
t ~N ( 0 ,V e), where Ve accounts for
the non-independence between repeated eij
t. Such infor-
mation could be collected from quarters of experimen-
tally infected cows, as was done in the study of [44].
Conclusions
In summary, this paper presents a novel epidemic model
to explore the effects of tolerance and resistance on per-
formance and disease spread in a population. Although
more research is necessary to validate the model and
more empirical studies are needed to obtain values for
the input parameters, the analytic approach can be used
to find optimal strategies of disease control in commer-
cial populations.
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